human
coronaviru
hcov
strain
infect
hcov
strain
infect
monocytesmacrophag
healthi
donor
patient
multipl
sclerosi
remiss
result
increas
apoptosi
measur
dna
chang
annexin
v
stain
apoptosi
correl
differenti
releas
infecti
viru
hcov
strain
titer
tissu
cultureinfect
dose
tcid
ml
hcov
strain
titer
tcid
ml
human
coronavirus
hcov
caus
upper
respiratori
ill
fall
two
serogroup
group
group
import
either
serogroup
caus
diseas
outsid
respiratori
tract
determin
coronaviruslik
particl
observ
electron
microscopi
perivascular
lesion
brain
patient
multipl
sclerosi
ms
sequenc
nucleocapsid
gene
serogroup
found
brain
macrophag
infect
contribut
pathogenesi
member
order
nidoviral
porcin
reproduct
respiratori
syndrom
viru
turkey
hemorrhag
enter
viru
murin
hepat
viru
mhv
encephalomyel
virusinduc
demyelin
diseas
show
similar
ms
follow
infect
mhv
strain
apoptosi
detect
macrophag
brain
parenchyma
demyelin
lesion
mhv
jhm
model
macrophag
infiltr
central
nervou
system
becom
activ
express
chemokin
receptor
induc
nitric
oxid
synthas
gamma
interferoninduc
factor
macrophag
activ
induc
resist
apoptosi
suggest
surviv
essenti
releas
inflammatori
mediat
reactiv
free
radic
speci
given
serogroup
hcov
infect
macrophag
hcov
strain
caus
cell
round
detach
occasion
syncytia
sought
determin
whether
apoptosi
induc
studi
approv
institut
review
board
state
univers
new
york
buffalo
peripher
blood
monocytesmacrophag
obtain
agematch
healthi
adult
donor
patient
diagnos
ms
remiss
receiv
medic
h
cultur
adher
cell
infect
hcov
strain
multipl
infect
assay
done
day
pair
normal
ms
monocytesmacrophag
hcov
strain
use
obtain
american
type
cultur
collect
manassa
va
plaqu
purifi
twice
grown
cell
infecti
viru
titer
sampl
quantit
immunoperoxidas
assay
antivir
monoclon
antibodi
mab
spike
antigen
hcov
strain
hcov
strain
cultur
harvest
day
postinfect
pi
evalu
hcov
strain
blood
monocyt
macrophag
produc
viral
titer
tissu
cultureinfect
dose
tcid
ml
hcov
strain
cell
produc
viral
titer
tcid
ml
fig
b
hcov
strain
infect
cell
appear
pyknot
granular
swell
plasma
membran
syncytia
h
pi
number
syncytia
increas
time
titer
cytopath
effect
similar
previous
report
hcov
strain
infect
proceed
without
cytopath
effect
low
titer
compar
amount
viru
detect
h
incub
two
wash
remov
inoculum
cultur
kept
day
titer
increas
slightli
tcid
ml
viabil
compar
uninfect
control
previous
hcov
strain
titer
pfuml
obtain
umbil
cord
blood
monocytesmacrophag
confirm
viral
titer
measur
inde
associ
infect
monocyt
macrophag
immunofluoresc
microscopi
perform
mab
viral
antigen
block
fc
receptor
normal
goat
serum
dako
carpinteria
calif
cell
stain
viral
antigen
express
surfac
paraformaldehyd
fix
cell
cultur
infect
hcov
strain
major
cell
express
viral
antigen
day
pi
similar
earlier
work
follow
hcov
strain
infect
cell
express
viral
antigen
compar
cord
bloodderiv
monocytesmacrophag
posit
viral
nucleocapsid
antigen
fig
suggest
replic
depend
level
differenti
cell
preferenti
viral
replic
less
differenti
tissu
observ
primari
neuron
deriv
dorsal
root
ganglia
astrocyt
cultur
healthi
donor
ms
patient
gave
similar
respons
within
paramet
experi
next
apoptosi
quantifi
termin
deoxynucleotidyltransferas
tdt
label
deadend
colorimetr
apoptosi
detect
system
promega
accord
manufactur
instruct
tdt
assay
done
prepar
monocytesmacrophag
differ
use
infect
assay
assay
result
directli
compar
respons
hcov
strain
inocul
monocytemacrophag
cell
posit
tdt
stain
tabl
hcov
strain
infect
proceed
signific
differ
apoptosi
compar
mockinfect
monocytesmacrophag
healthi
subject
ms
patient
gave
similar
respons
verifi
hcov
strain
infect
induc
apoptot
chang
monocytesmacrophag
flow
cytometr
analysi
cell
membran
express
extern
phosphatidylserin
perform
doubl
label
hcov
strain
monocytesmacrophag
healthi
donor
annexin
v
vital
dye
monocytemacrophag
cell
cultur
h
infect
hcov
strain
multipl
mock
infect
incub
h
wash
twice
remov
inoculum
h
infect
variou
interv
thereaft
cell
duplic
wash
phosphatebuff
salin
pb
incub
l
pharmacia
wash
bind
buffer
mm
hepe
mm
nacl
mm
cacl
cell
incub
l
human
annexin
vphycoerythrin
pe
r
system
inc
volum
bind
buffer
ad
cell
kept
ice
analyz
coulter
epic
xlmcl
flow
cytomet
within
h
stain
data
cell
collect
six
donor
examin
standard
deviat
calcul
membran
extern
phosphatidylserin
indic
annexin
vpe
cell
increas
significantli
h
pi
fig
fortysix
percent
infect
cell
gave
displac
annexin
vpe
signal
cutoff
valu
unstain
cell
compar
mockinfect
cell
fig
differ
apoptosi
versu
annexin
v
data
tdt
data
may
due
timedepend
factor
plasma
membran
annexin
v
expos
earlier
apoptosi
fragment
also
infect
cultur
number
attach
cell
reduc
h
infect
compar
reduct
uninfect
cultur
presum
cell
becom
infect
detach
throughout
infect
examin
hcov
strain
cell
viral
spike
antigen
express
monocytesmacrophag
healthi
donor
cultur
h
infect
hcov
strain
multipl
incub
h
wash
twice
pb
incub
rpmi
medium
autolog
serum
h
variou
interv
thereaft
cell
duplic
preincub
l
undilut
normal
timedepend
express
cell
membran
hcov
strain
antigen
monocytesmacrophag
observ
fig
h
pi
infect
cell
show
immunofluoresc
compar
well
previou
report
half
attach
infect
cell
fluoresc
h
pi
displac
increas
signal
intens
virusspecif
mab
compar
isotyp
control
mab
seen
fig
percentag
viabl
cell
measur
trypan
blue
dye
exclus
respect
day
pi
uninfect
cell
remain
viabl
throughout
previous
viabil
infect
attach
cell
h
report
order
demonstr
apoptot
cell
inde
cell
infect
viru
doubl
stain
virusspecif
mab
antigen
annexin
vpe
per
form
monocytesmacrophag
three
donor
standard
deviat
calcul
interv
cytofluorometr
analysi
show
presenc
marker
viabl
cell
exclus
cell
show
dual
fluoresc
h
pi
fig
overal
increas
apoptot
cell
observ
hcov
strain
cultur
h
pi
associ
necrot
cell
normal
cultur
apoptot
cell
mockinfect
cultur
cell
like
enter
apoptot
pathway
cell
death
monocyt
normal
circul
blood
day
time
either
migrat
tissu
differenti
macrophag
die
apoptosi
apoptosi
caus
hcov
adher
monocytesmacrophag
cultur
might
due
commit
proapoptot
signal
gener
viru
possibl
product
cytokin
mediat
tumor
necrosi
factor
alpha
also
factor
sinc
differ
observ
percent
apoptosi
h
pi
versu
cell
stain
annexin
v
cell
immunostain
annexin
v
stain
fig
studi
cytokin
express
hcov
strain
monocytesmacrophag
necessari
clarifi
point
follow
infect
monocytesmacrophag
hcov
strain
viabil
remain
high
day
apoptosi
observ
low
viral
titer
confirm
demonstr
viral
spike
antigen
surfac
cell
infect
cultur
immunofluoresc
microscopi
lack
apoptosi
like
due
poor
abil
viru
infect
cell
studi
hcovinduc
apoptosi
monocyt
freshli
isol
person
clinic
activ
ms
would
appropri
monocytemacrophag
activ
observ
acut
exacerb
progress
ms
